Read More Pharma Industry News Johnson & Johnson strikes $1.2bn deal with Numab Therapeutics for atopic dermatitis candidate In a significant move to enhance its immunology offerings, Johnson & Johnson (NYSE: JNJ) has announced a definitive… byPallavi MadhirajuMay 30, 2024